Binge Drinking Impairs Vascular Function in Young Adults  by Goslawski, Melissa et al.
Journal of the American College of Cardiology Vol. 62, No. 3, 2013
 2013 by the American College of Cardiology Foundation ISSN 0735-1097/$36.00
Published by Elsevier Inc. http://dx.doi.org/10.1016/j.jacc.2013.03.049Binge Drinking Impairs Vascular Function
in Young Adults
Melissa Goslawski, MS,* Mariann R. Piano, PHD,y Jing-Tan Bian, PHD,* Emily C. Church, BS,*
Mary Szczurek, BS,* Shane A. Phillips, PT, PHD*z
Chicago, IllinoisFrom the *
Chicago, Il
Illinois at C
of Illinois a
Institutes of
HL095701
Illinois at C
UL1RR029
The conten
represent th
National Ins
ships relevan
Manuscri
2013, acceptObjectives TDepartment of Physical
linois; yDepartment of
hicago, Chicago, Illinois;
t Chicago, Chicago, Illi
Health grants AA015578
(to Dr. Phillips). This p
hicago, Center for Clin
879 from the National C
t is solely the responsib
e ofﬁcial views of the N
titutes of Health. The au
t to the contents of this
pt received December 5,
ed March 19, 2013.he aim of this study was to assess whether young binge drinkers (BD) have impaired macrovascular and
microvascular function and cardiovascular disease risk factors compared with age-matched alcohol
abstainers (A).Background Binge drinking rates are highest on college campuses and among those age 18 to 25 years; however,
macrovascular and microvascular endothelial function in young adults with histories of repeated binge drinking
(5 standard drinks in 2 h in men, 4 standard drinks in 2 h in women) has not been investigated.Methods Cardiovascular proﬁles, brachial artery endothelial-dependent ﬂow-mediated dilation (FMD), and ﬂow-independent
nitroglycerin (NTG)–mediated dilation and vasoreactivity of resistance arteries (isolated from gluteal fat biopsies)
were evaluated in A and BD.Results Men and women (18 to 25 years of age; A, n ¼ 17; BD, n ¼ 19) were enrolled. In the BD group, past-month mean
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the BD group compared with the A group (p ¼ 0.032). No differences between groups were found in blood pressure,
lipoproteins, and C-reactive protein.Conclusions Alterations in the macrocirculation and microcirculation may represent early clinical manifestations of
cardiovascular risk in otherwise healthy young BD. This study has important clinical implications for screening young
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spective studies enrolling adults ranging in age from 40 to 60
years have found that binge drinking is associated with
a heightened risk for cardiovascular (CV) events, such as
stroke, sudden death, myocardial infarction, and increased
mortality after myocardial infarction (5–8). Others have re-
ported that an alcohol binge drinking pattern is associated
with progression of carotid atherosclerosis (9). Several
mechanisms may underlie the increased risk for adverse CV
events; however, a central mechanism may be changes in
vascular biology, such as endothelial dysfunction.See page 208The endothelium is a key regulator of vascular function.
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202for future CV events (10,11). Im-
paired endothelium-independent
dilation, reﬂective of smooth mus-
cle dysfunction, is also linked
to the development of athero-
sclerosis. Flow-mediated dilation
(FMD) and nitroglycerin (NTG)–
mediated dilation of the brachial
artery are commonly used to eval-
uate endothelial-dependent and
endothelial-independent func-
tion, respectively. To our knowl-
edge, endothelial function in
young adults with repeated his-
tories of binge drinking has
not been investigated, nor have
studies simultaneously evaluated
macrovascular and microvascular
endothelial function. Endothelial
cells can differ in structure and
physiologic function, dependingon the vasculature bed, making it clinically important to
study vascular function at multiple vascular sites. This study
was designed to test the hypothesis that young binge
drinkers (BD) have impaired macrovascular and micro-
vascular function compared with age-matched alcohol
abstainers (A).Methods
Study subjects and protocol. Thirty-eight nonsmoking
healthy subjects were recruited from an urban university
setting into this study: A (10 men, 9 women) and BD
(11 men, 6 women). BD were deﬁned as those who con-
sumed5 standard drinks (12 oz beer, 5 oz table wine, 1.5 oz
80-proof spirits, or 8 to 9 oz malt liquor) in a 2-h period in
the past 2 weeks if male and 4 standard drinks in a 2-h
period in the past 2 weeks if female (2). A were deﬁned as
those who consumed no more than 1 to 5 standard drinks
in the past year. Exclusion criteria were history of diabetes,
hypertension, pregnancy, CV disease or events, thyroid
disease, pituitary tumor, a genetic disease causing disability,
gout, illicit drug use, and body mass index 30 kg/m2. The
study was approved by the Ofﬁce of Protection of Research
Subjects and Institutional Review Board, and written consent
was obtained from all subjects.
In all subjects, the following tests were performed: fasting
lipid panel (total cholesterol, high-density lipoprotein
cholesterol, low-density lipoprotein cholesterol, and triglyc-
erides), insulin and glucose, complete blood count dif-
ferential, C-reactive protein (CRP), and blood alcohol
levels (Alverno Clinical Laboratories, Hammond, Indiana).
Venous samples were drawn into a serum tube and an eth-
ylenediaminetetraacetic acid–containing tube. Also measured
were resting blood pressure (BP), heart rate, oxygen satura-
tion, and temperature. Gluteal fat pad biopsies wereperformed, and resistance arteries were isolated for isolated
perfused microvessel experiments.
All subjects completed questionnaires about medical his-
tory, diet, and alcohol beverage consumption. The Block
Brief 2000 Food Frequency Questionnaire (NutritionQuest,
Berkeley, California) was used to obtain information about
diet. Alcohol consumption (pattern and frequency) was
estimated using a modiﬁed version of the 6-item set
of questions on binge drinking (12). Three additional
questions were included on binge drinking that addressed
the type of alcohol consumed, history of familial alcohol
abuse, and duration of binge drinking. For BD, the rate
of alcohol consumption (grams per hour) was calculated
on the basis of their most recent binge drinking epi-
sode (rate ¼ total grams of alcohol consumed/time spent
consuming alcohol).
Measurement of FMD. All imaging studies were per-
formed in the morning after an overnight fast. Similar to
previously reported protocols and methods, ultrasound
imaging was conducted using the MicroMaxx ultrasound
machine (SonoSite, Seattle, Washington) (13). Imaging of
the brachial artery was performed in a longitudinal plane, at
approximately 5 cm proximal to the antecubital fossa of the
right arm, abducted approximately 80 from the body, with
the forearm supinated. The ultrasound probe (11 MHz) was
positioned at a 60 insonation angle to visualize the anterior
and posterior lumen-intima interfaces, to measure diameter
or central ﬂow velocity (pulsed Doppler). After baseline
ultrasound imaging, Doppler readings of peak ﬂow and mean
ﬂow were performed for at least 5 s. A BP cuff was placed on
the forearm, distal to the antecubital fossa of the imaged arm,
and inﬂated to 60 mm Hg above baseline systolic BP for
5 min. Once the cuff was released, BP and heart rate
measurements in the opposite arm were taken, along with
Doppler readings of the ﬁrst 10 s after cuff release. The
brachial artery was then imaged continuously to capture 30 s,
1 min, 2 min, and 3min after BP cuff release. The response to
NTG was used for the determination of endothelium-
independent vasodilation. After obtaining a baseline
(resting) brachial artery image, a sublingual NTG tablet (0.4
mg) was administered, and brachial artery images and
measurements were repeated and obtained as detailed earlier.
Images were digitally recorded using Brachial Imagery
(Medical Imaging, Iowa City, Iowa) and analyzed as
previously described (13). Four hundred ﬁfty frames were
captured, digitized, and analyzed from the M-line (the
border between the intima and media of the brachial
artery) of the same location of blood vessel using visible
landmarks with edge detection software. Approximately
75 frames (7.5 frames/s for 10 s) were analyzed for each
baseline and time point measurement through a mean
of brachial artery diameters over the entire RR interval.
FMD and the response to NTG were calculated using the
averaged minimal mean brachial artery diameter at baseline
compared with the largest mean values obtained after
release of the forearm occlusion or administration of NTG.
Table 1 Demographic and Metabolic Characteristics
Characteristic
Abstainers
(n ¼ 19)
Binge Drinkers
(n ¼ 17) p Value
Median age (yrs) 24.5 23 0.526
25th percentile 21 21.5
75th percentile 29 25
Men 53% 65% 0.463
White 21% 76% 0.004
Body mass index (kg/m2) 23.7  0.9 25.0  1 0.370
Systolic blood pressure
(mm Hg)
114  3 120  2 0.092
Diastolic blood pressure
(mm Hg)
67  1 70  2 0.163
Heart rate (beats/min) 64  1 65  2 0.800
Total cholesterol (mg/dl) 162.16  8.88 166.12  6.18 0.689
Median LDL cholesterol
(mg/dl)
82 86 0.975
25th percentile 67 67
75th percentile 118 107
HDL cholesterol (mg/dl) 54.83  3.09 61.78  5.02 0.21
Median triglycerides (mg/dl) 61.0 78.5 0.159
25th percentile 44.0 62.2
75th percentile 104 98.7
Glucose (mg/dl) 85.05  1.98 89.01  1.98 0.167
Insulin (mIU/l) 6.48  1.09 4.69  0.71 0.167
CRP (mg/dl) 1.29  0.59 1.60  0.70 0.421
Blood alcohol (%) ND 0.01  0.002 0.762
AST (IU/l) 19  1 23  2 0.058
ALT (IU/l) 9  1 11  1 0.249
Values are mean  SEM or % except as indicated.
ALT ¼ alanine aminotransferase; AST ¼ aspartate aminotransferase; CRP ¼ C-reactive protein;
HDL ¼ high-density lipoprotein; LDL ¼ low-density lipoprotein.
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203The coefﬁcient of variation (intraobserver) was 1.5% for
brachial artery diameter, 6.3% for FMD, and 3.2% for
NTG-induced dilation. The peak ﬂow velocity was observed
from 5 seconds of baseline diameter Doppler readings,
and 10 s of post–cuff release Doppler readings were
recorded for shear rate calculations. Shear rate was cal-
culated as blood velocity (cm/s) divided by vessel diameter
(cm) (14).
Gluteal adipose biopsy and resistance artery function.
Microvessels in subcutaneous fat are easily accessible and
have been used to investigate microvascular function in
humans (15). Approximately 2 ml of fat tissue was removed
and transferred to (4C) HEPES solution. Resistance
arteries (approximately 150 mm) were isolated and cannu-
lated in an organ chamber with glass micropipettes ﬁlled with
KREBS solution (pH ¼ 7.40) (16). Both ends of the vessel
were secured, and the vessel was maintained at an intra-
luminal pressure of 20 mm Hg for 30 min, after which
intraluminal pressure was gradually increased to 60 mm Hg
for an additional 30 min. Preparations were visualized with
video cameras and monitors (model VIA-100, Boeckeler,
Tucson, Arizona). After the 30-min equilibration period,
vessels were constricted (30% to 50% of baseline diameter)
with endothelin (ET)-1 (100 to 200 pmol/l ﬁnal concen-
tration), and dose-response curves were measured using
acetylcholine (ACh) (109 to 104 mol/l; A, n ¼ 10; BD,
n ¼ 12) and the nitric oxide (NO) donor sodium nitro-
prusside (SNP) (109 to 104 mol/l; A, n ¼ 8; BD, n ¼ 8).
Resistance arteries were monitored continuously, and
internal diameters were measured at the maximal diameter
after each dilator dose. Dose responses to ACh were
measured in the absence and presence of the NO synthase
inhibitor N-nitro-L-arginine methyl ester (L-NAME)
(104 mol/l; A, n ¼ 9; BD, n ¼ 11). Maximal responses
to papaverine (104 mol/l) were measured at the end of
each dose response of ACh. In separate experiments, also
determined were constrictor responses to ET-1 (1011 to
107 mol/l; A, n ¼ 9, BD, n ¼ 10).
Materials. The pharmacological compounds L-NAME,
ACh, SNP, and ET-1 were obtained from Sigma-
Aldrich Corporation (St. Louis, Missouri). Chemical
reagents for buffer solutions were purchased from Sigma-
Aldrich Corporation and Fisher Scientiﬁc (San Jose,
California).
Statistical analysis. Analyses were conducted using SAS
version 9.3 (SAS Institute Inc., Cary, North Carolina) and
SigmaPlot version 12.0 (SigmaPlot, San Jose, California).
All data are reported as mean  SE, with p < 0.05
considered signiﬁcant unless otherwise noted. Nutritional
questionnaires were sent to NutritionQuest for calorie and
other nutrient analysis. Normality was tested using the
Shapiro-Wilk test. The A and BD group differences were
determined using independent t tests. Mann-Whitney U
tests were used for continuous variables (e.g., demographics,
CRP, lipids, FMD, and NTG-mediated dilation) and chi-
square tests for categorical variables. For dose-responseexperiments, data are expressed as percentages, with 100%
representing the change from constricted diameter to the
maximal diameter at 60 cm H2O intraluminal pressure.
Dose responses to ACh (with or without L-NAME), SNP,
and ET-1 were compared using a 2-factor, repeated-
measures analysis of variance with a Bonferroni adjust-
ment. ET-1 half maximal effective concentration (EC50)
values were computed using SigmaPlot with the Dynamic
Fit Wizard and with an equation (Y ¼ min þ max  min/
1 þ 10(logEC50X) Hillslope) for XY pair data.
Analyses of covariance were performed on endothelium-
dependent and endothelium-independent vasodilation, to
examine the relationship of binge drinking, controlling for
covariates (age, sex, and ethnicity) using a general linear
model. Covariates were tested with binge drinking status
individually because of the small sample size. Effect sizes
and 95% conﬁdence intervals (CIs) were computed without
covariates (17).
Results
Clinical characteristics. Demographic characteristics were
not signiﬁcantly different between the A and BD groups
(Table 1); however, BD were more likely to be white
(p ¼ 0.004). Nutritional histories (macronutrient and
micronutrient intake) and white and red blood cell values
Table 2 Brachial Artery Characteristics
Variable
Abstainers
(n ¼ 19)
Binge Drinkers
(n ¼ 17) p Value
Baseline brachial FMD diameter (mm) 3.5  0.1 3.9  0.2 0.049
Maximal brachial FMD diameter (mm) 3.9  0.1 4.3  0.2 0.053
D ﬂow (cm/s) 98  12 80  10 0.176
Peak ﬂow (cm/s) 142  7 128  9 0.142
D shear rate (s) 98  12 95  15 0.433
Peak shear rate (s) 412  18 328  20 <0.005
Baseline brachial NTG-mediated dilation diameter (mm) 3.5  0.1 4.00  0.2 0.017
Maximal brachial NTG-mediated dilation diameter (mm) 4.5  0.1 4.8  0.2 0.153
Values are mean  SEM.
FMD ¼ ﬂow-mediated dilation; NTG ¼ nitroglycerin.
Figure 1
Brachial FMD and NTG-Induced Dilation
in the A and BD Groups
Brachial ﬂow-mediated dilation (FMD) (top) and nitroglycerin (NTG)–induced
dilation (bottom) were signiﬁcantly lower in binge drinkers (BD) compared with
alcohol abstainers (A) (p ¼ 0.022 and p ¼ 0.009, respectively). Values are
mean  SEM.
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shown). All lipid values and CRP were similar between
groups (Table 1). The mean time since the last binge
episode in the BD group was 65  11 h. Subjects in the BD
group drank alcohol at a rate of 34  7 g. During the month
before the study, the mean number of binge episodes in the
BD group was 6  1. The mean duration of binge drinking
behavior was 4  0.6 years.
Brachial artery endothelium-dependent and endothelium-
independent dilation. Except for baseline brachial FMD
diameter and change in shear rate, blood vessel characteristics
were not different between the A and BD groups (Table 2).
Unadjusted FMD and NTG-induced dilation were signiﬁ-
cantly lower in the BD group compared with the A group
(p ¼ 0.022 and p ¼ 0.009, respectively) (Fig. 1). When
baseline brachial artery diameter was tested as a predictor,
there remained a signiﬁcant difference between groups,
though the effect was slightly attenuated. The effect size (eta
squared) was 0.25 (95% CI: 0.023 to 0.47) for FMD and
0.61 (95% CI: 0.32 to 0.74) for NTG-mediated dilation.
Also, because the BD group had a higher proportion of white
subjects, this variable was tested individually as a covariate in
a multivariate model, as well as age and sex. No covariates
were statistically signiﬁcant.
Microvascular resistance artery endothelium-dependent
and endothelium-independent dilation. ACh-induced
dilation in resistance arteries was not signiﬁcantly different
between the A and BD groups (p ¼ 0.365) (Fig. 2). The
presence of L-NAME signiﬁcantly blocked ACh-induced
dilation in the A group (p ¼ 0.002) but not in the BD
group (p¼ 0.155). SNP-induced dilation in resistant arteries
was not signiﬁcantly different between groups (p ¼ 0.948)
(Fig. 3). Because ET-1 was used to pre-constrict vessels
before ACh dose-response experiments, we compared the
dose used for pre-constriction, and there was no signiﬁcant
difference between groups (A, 1.6  108; BD, 1.4  108;
p ¼ 0.442).
At several concentrations tested, ET-1–induced
constriction was signiﬁcantly enhanced in the BD group
compared with the A group (p ¼ 0.002) (Fig. 4). EC50 for
ET-1 was signiﬁcantly more potent in the BD group (9.4 
0.1 nmol/l) than the A group (8.7 0.3 nmol/l) (p¼ 0.032).Discussion
We demonstrate that young adults with normal serum
lipoprotein, triglyceride, CRP, glucose, and insulin levels
and histories of binge drinking (mean 4 years) had reduced
FMD and NTG-induced dilation. This study addressed the
importance of binge drinking on macrovascular and
Figure 4 ET-1–Induced Constriction in the A and BD Groups
Endothelin (ET)-1–induced constriction was signiﬁcantly greater in binge drinkers
(BD) (n ¼ 10) compared with alcohol abstainers (A) (n ¼ 10) (p ¼ 0.002).
Values are mean  SEM. *Signiﬁcant difference (p  0.01).
Figure 2 ACh-Induced Dilation in the A and BD Groups
Acetylcholine (ACh)–induced dilation in resistance arteries was similar between
alcohol abstainers (A) (n ¼ 11) and binge drinkers (BD) (n ¼ 10) (p ¼ .365).
N-nitro-L-arginine methyl ester (L-NAME) signiﬁcantly blocked ACh-induced dilation
in the A group (p ¼ 0.007) but not in the BD group (p ¼ 0.155). Values are
mean  SEM. *Signiﬁcant difference (p  0.008) between ACh-induced dilation
and ACh þ L-NAME–induced dilation in the A group.
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vascular beds.
Binge drinking and macrovascular function. Our ﬁnd-
ings of impairment in brachial artery endothelial-dependent
and endothelial-independent vasodilation are similar to
those of others who have examined the one-time effect of
a single binge episode on endothelial function (18–20). Bau
et al. (19) found that FMD and NTG-induced dilation were
impaired 4 h after alcohol intoxication, returning to baselineFigure 3 SNP-Induced Dilation in the A and BD Groups
Sodium nitroprusside (SNP)–induced dilation was similar between alcohol
abstainers (A) (n ¼ 5) and binge drinkers (BD) (n ¼ 6) (p ¼ 0.948). Values are
mean  SEM.levels 13 h after alcohol intoxication. There are also reports
that FMD is impaired in abstinent subjects with long-term
histories of alcohol abuse or alcoholism (21–23). Our ﬁnd-
ings suggest that young BD have developed FMD impair-
ments that are equivalent to those found in subjects with
lifetime histories of daily heavy alcohol consumption
(>6 drinks/day for >8 years). Because our subjects were
tested 24 to 96 h after their most recent binge drinking
episodes, the time course for restoration of FMD that might
occur with the cessation of binge drinking is unknown. It is
important to note that NTG-mediated dilation was also
reduced in BD, suggesting that there could be reduced
smooth muscle cell responses to NO and altered post-
receptor signal transduction events, such as alterations in
the cyclic guanosine monophosphate pathway.
Binge drinking and microvascular function. A unique
aspect of our study was the use of subcutaneous gluteal fat
pad biopsy to study isolated resistance arteries under ex vivo
conditions. In contrast to decreased FMD in the brachial
arteries of the BD group, there were no differences between
groups in response to all doses of the endothelium-
dependent vasodilator ACh and the NO donor SNP. Our
results suggest that the effects of binge drinking on FMD
and ACh-induced and SNP-induced dilation are divergent.
In addition, L-NAME had no inhibitory effect on ACh-
induced dilations, which implies the possibility that other
endothelial or non-endothelium-dependent pathways may
be involved in vasodilation in resistance arteries. These
differences may relate to the experimental preparation and
the absence of circulating vasoconstrictor mediators in the
ex vivo preparation, such as norepinephrine or ﬂow stimuli
(shear stress vs. ACh). Also, others have reported that
dilations to ﬂow and ACh can be divergent in the context of
pathological conditions (i.e., high cholesterol) (24).
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reduced, and other endothelium-derived dilator substances
or non-endothelium-derived factors, such as hydrogen
peroxide, may compensate for the lack of NO (16,25). Both
acute and long-term ethanol exposure is associated with the
excessive generation of reactive oxygen species and oxidative
stress and is believed to play a central role in alcohol toxicity
(26). Yogi et al. (27) found that ethanol (100 mmol)
increased superoxide and hydrogen peroxide generation in
cultured aorta vascular smooth muscle cells. Others have
found that impairments in NO-dependent vasorelaxation
occurred with increased reactive oxygen species production
and overproduction of ET-1 (28). Although in our study,
circulating ET-1 levels were not measured, we found
enhanced ET-1–induced constrictions and a lower EC50 in
the BD compared with the A group, indicating increased
vasoconstrictor responsiveness to ET-1 (Fig. 3). ET-1 may
reduce NO production and increase NO degradation (29),
and increased plasma levels of ET-1 have been found in
heavy alcohol consumers (23,30), making it important to
elucidate the effects of binge drinking on ET-1 and ET-1
receptors in the setting of binge drinking.
Binge drinking and accelerated atherosclerosis. In other
populations, such as healthy postmenopausal women,
endothelial dysfunction was found to be signiﬁcantly asso-
ciated with the future development of hypertension (31). In
the CARDIA (Coronary Artery Risk Development in
Young Adults) study, Pletcher et al. (32) found that binge
drinking in adults (mean age 25.2 years) was signiﬁcantly
associated with greater coronary calciﬁcation, suggesting the
presence of coronary artery atherosclerosis. Recently, Liu
et al. (33) reported that binge drinking rather than daily
moderate drinking was associated with accelerated plaque
development in a mouse model of accelerated atheroscle-
rosis. Also, in a prospective evaluation of adults admitted for
ﬁrst-ever brain infarction, Hillbom et al. (34) found that
acute intake of more than 40 g of ethanol during the 24 h
preceding the brain infarction on weekends and holidays was
signiﬁcantly associated with cerebral infarction in young (16
to 40 years) and middle-age (41 to 60 years) subjects. One
mechanism suggested for the binge-associated increased
stroke risk is hypertension; however, at least in younger
subjects, hypertension prevalence is low. These data from
both epidemiologic and animal models suggest the need to
evaluate the pattern of alcohol consumption in relationship
to CV risk and adverse events.
Study limitations. This study had important limitations
related to both clinical sample and study design. We had
a small sample size, and the study was cross-sectional,
warranting future longitudinal assessment. We also used
self-report to measure alcohol consumption. Others, though,
have shown that self-report methods offer a reliable and
valid approach to measuring alcohol consumption (35).
Another limitation may relate to the greater baseline brachial
artery diameter and lower peak shear rates found in the BD
group. The latter may contribute to the lower FMD in theBD group because larger baseline diameters are associated
with reduced FMD (36). Our results, though, show that
there is a signiﬁcant effect of binge drinking on FMD and
NTG-induced dilation, even after correcting for baseline
diameter as a covariate.
Conclusions
Young adults without histories of CV disease who engaged
in frequent and heavy episodic binge drinking had reduced
FMD and NTG-induced dilation. The microvascular
vasodilator responses to ACh and SNP were not different
between groups; however, microvessels isolated from the
BD group had enhanced vasoconstrictor responses to the
potent vasoconstrictor ET-1. Our data show alterations in
macrovascular and microvascular function associated with
binge drinking that are similar to those seen in association
with recognized CV risk factors. This study adds to a
growing chain of evidence suggesting that, in contrast to
regular and moderate alcohol consumption, binge drinking
may be a risk factor for future clinical CV disease.
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